Next Article in Journal
Impact of Front-of-Pack Nutrition Labels on Portion Size Selection: An Experimental Study in a French Cohort
Previous Article in Journal
The Dirt on Clean Eating: A Cross Sectional Analysis of Dietary Intake, Restrained Eating and Opinions about Clean Eating among Women
Previous Article in Special Issue
Long-Term Diet Supplementation with Lactobacillus paracasei K71 Prevents Age-Related Cognitive Decline in Senescence-Accelerated Mouse Prone 8
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Nutrients 2018, 10(9), 1267; https://doi.org/10.3390/nu10091267

The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials

1
IRCCS Fondazione Don Carlo Gnocchi, 20100 Milan, Italy
2
Department of Physiopathology and Transplants, University of Milano, 20100 Milan, Italy
3
Department of Biology and Biotechnology, University of Pavia, 27100 Pavia, Italy
4
Istituto per lo Studio e la Cura del Diabete [ISCD], Casagiove, 81022 Caserta, Italy
*
Author to whom correspondence should be addressed.
Received: 24 August 2018 / Revised: 5 September 2018 / Accepted: 6 September 2018 / Published: 8 September 2018
(This article belongs to the Special Issue Brain Aging and Gut-Brain Axis)
Full-Text   |   PDF [1046 KB, uploaded 8 September 2018]   |  

Abstract

Despite intensive study, neurodegenerative diseases remain insufficiently understood, precluding rational design of therapeutic interventions that can reverse or even arrest the progressive loss of neurological function. In the last decade, several theories investigating the causes of neurodegenerative diseases have been formulated and a condition or risk factor that can contribute is described by the gut-brain axis hypothesis: stress, unbalanced diet, and drugs impact altering microbiota composition which contributes to dysbiosis. An altered gut microbiota may lead to a dysbiotic condition and to a subsequent increase in intestinal permeability, causing the so-called leaky-gut syndrome. Herein, in this review we report recent findings in clinical trials on the risk factor of the gut-brain axis in Alzheimer’s disease and on the effect of omega-3 supplementation, in shifting gut microbiota balance towards an eubiosis status. Despite this promising effect, evidences reported in selected randomized clinical trials on the effect of omega-3 fatty acid on cognitive decline in Alzheimer’s disease are few. Only Mild Cognitive Impairment, a prodromal state that could precede the progress to Alzheimer’s disease could be affected by omega-3 FA supplementation. We report some of the critical issues which emerged from these studies. Randomized controlled trials in well-selected AD patients considering the critical points underlined in this review are warranted. View Full-Text
Keywords: Alzheimer’s disease; neuroinflammation; microbiota; neurodegeneration; cognitive impairment; omega-3 Alzheimer’s disease; neuroinflammation; microbiota; neurodegeneration; cognitive impairment; omega-3
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

La Rosa, F.; Clerici, M.; Ratto, D.; Occhinegro, A.; Licito, A.; Romeo, M.; Iorio, C.D.; Rossi, P. The Gut-Brain Axis in Alzheimer’s Disease and Omega-3. A Critical Overview of Clinical Trials. Nutrients 2018, 10, 1267.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top